FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q39442213> ?p ?o ?g. }

• Q39442213 description "2016 nî lūn-bûn" @default.
• Q39442213 description "2016年の論文" @default.
• Q39442213 description "2016年学术文章" @default.
• Q39442213 description "2016年学术文章" @default.
• Q39442213 description "2016年学术文章" @default.
• Q39442213 description "2016年学术文章" @default.
• Q39442213 description "2016年学术文章" @default.
• Q39442213 description "2016年學術文章" @default.
• Q39442213 description "2016年學術文章" @default.
• Q39442213 description "2016年學術文章" @default.
• Q39442213 description "2016年學術文章" @default.
• Q39442213 description "2016年學術文章" @default.
• Q39442213 description "2016年學術文章" @default.
• Q39442213 description "2016년 논문" @default.
• Q39442213 description "article científic" @default.
• Q39442213 description "article scientific" @default.
• Q39442213 description "article scientifique (publié 2016)" @default.
• Q39442213 description "articol științific" @default.
• Q39442213 description "articolo scientifico" @default.
• Q39442213 description "artigo científico (publicado na 2016)" @default.
• Q39442213 description "artigo científico (publicado na 2016)" @default.
• Q39442213 description "artigo científico" @default.
• Q39442213 description "artikull shkencor" @default.
• Q39442213 description "artikulong pang-agham" @default.
• Q39442213 description "artykuł naukowy" @default.
• Q39442213 description "artículo científico publicado en 2016" @default.
• Q39442213 description "artículu científicu espublizáu en 2016" @default.
• Q39442213 description "bilimsel makale" @default.
• Q39442213 description "bài báo khoa học" @default.
• Q39442213 description "mokslinis straipsnis" @default.
• Q39442213 description "naučni članak" @default.
• Q39442213 description "scienca artikolo" @default.
• Q39442213 description "scientific article" @default.
• Q39442213 description "teaduslik artikkel" @default.
• Q39442213 description "tieteellinen artikkeli" @default.
• Q39442213 description "tudományos cikk" @default.
• Q39442213 description "vedecký článok" @default.
• Q39442213 description "vetenskaplig artikel" @default.
• Q39442213 description "videnskabelig artikel (udgivet 2016)" @default.
• Q39442213 description "vitenskapelig artikkel" @default.
• Q39442213 description "vitskapeleg artikkel" @default.
• Q39442213 description "vědecký článek" @default.
• Q39442213 description "wetenschappelijk artikel" @default.
• Q39442213 description "wissenschaftlicher Artikel" @default.
• Q39442213 description "επιστημονικό άρθρο" @default.
• Q39442213 description "мақолаи илмӣ" @default.
• Q39442213 description "мақолаи илмӣ" @default.
• Q39442213 description "наукова стаття, опублікована в серпні 2016" @default.
• Q39442213 description "научна статия" @default.
• Q39442213 description "научная статья" @default.
• Q39442213 description "научни чланак" @default.
• Q39442213 description "научни чланак" @default.
• Q39442213 description "գիտական հոդված" @default.
• Q39442213 description "מאמר מדעי" @default.
• Q39442213 description "سائنسی مضمون" @default.
• Q39442213 description "مقالة علمية" @default.
• Q39442213 description "مقالهٔ علمی" @default.
• Q39442213 description "২০১৬-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
• Q39442213 description "บทความทางวิทยาศาสตร์" @default.
• Q39442213 description "სამეცნიერო სტატია" @default.
• Q39442213 name "Efficacy of alirocumab in high cardiovascular risk populations with or without heterozygous familial hypercholesterolemia: Pooled analysis of eight ODYSSEY Phase 3 clinical program trials" @default.
• Q39442213 name "Efficacy of alirocumab in high cardiovascular risk populations with or without heterozygous familial hypercholesterolemia: Pooled analysis of eight ODYSSEY Phase 3 clinical program trials" @default.
• Q39442213 name "Efficacy of alirocumab in high cardiovascular risk populations with or without heterozygous familial hypercholesterolemia: Pooled analysis of eight ODYSSEY Phase 3 clinical program trials" @default.
• Q39442213 type Item @default.
• Q39442213 label "Efficacy of alirocumab in high cardiovascular risk populations with or without heterozygous familial hypercholesterolemia: Pooled analysis of eight ODYSSEY Phase 3 clinical program trials" @default.
• Q39442213 label "Efficacy of alirocumab in high cardiovascular risk populations with or without heterozygous familial hypercholesterolemia: Pooled analysis of eight ODYSSEY Phase 3 clinical program trials" @default.
• Q39442213 label "Efficacy of alirocumab in high cardiovascular risk populations with or without heterozygous familial hypercholesterolemia: Pooled analysis of eight ODYSSEY Phase 3 clinical program trials" @default.
• Q39442213 prefLabel "Efficacy of alirocumab in high cardiovascular risk populations with or without heterozygous familial hypercholesterolemia: Pooled analysis of eight ODYSSEY Phase 3 clinical program trials" @default.
• Q39442213 prefLabel "Efficacy of alirocumab in high cardiovascular risk populations with or without heterozygous familial hypercholesterolemia: Pooled analysis of eight ODYSSEY Phase 3 clinical program trials" @default.
• Q39442213 prefLabel "Efficacy of alirocumab in high cardiovascular risk populations with or without heterozygous familial hypercholesterolemia: Pooled analysis of eight ODYSSEY Phase 3 clinical program trials" @default.
• Q39442213 P1433 Q39442213-497FEDBB-A029-4C63-8346-4B428606D932 @default.
• Q39442213 P1476 Q39442213-A363DDB4-4E66-4B8C-ACCE-26877E8693BC @default.
• Q39442213 P2093 Q39442213-1627CAE5-50B4-47D8-A89A-182620A7C00F @default.
• Q39442213 P2093 Q39442213-39171944-0922-4C69-BE93-612752702B74 @default.
• Q39442213 P2093 Q39442213-4FFD09E3-C701-4DAF-AE88-F19361785D16 @default.
• Q39442213 P2093 Q39442213-A50FA162-F218-44D9-944B-0810B8861042 @default.
• Q39442213 P2093 Q39442213-EA39BCAC-BFAD-418E-A47E-815F67B149AF @default.
• Q39442213 P2093 Q39442213-FFCE116B-80AE-4C5E-A02A-83D1A8B189BA @default.
• Q39442213 P304 Q39442213-7B1557F4-CF8A-4448-BD33-EFE6B2CCF0CC @default.
• Q39442213 P31 Q39442213-BBF27B5F-9378-43F6-947B-E052ADAFDCD2 @default.
• Q39442213 P356 Q39442213-D15B8B25-27EB-4A46-8F24-9083F3FEBD3F @default.
• Q39442213 P407 Q39442213-C857CCCA-000E-4514-89AD-346A9CE19D2C @default.
• Q39442213 P478 Q39442213-14D98C19-91DB-4F7C-B2CA-32EA9DE849F7 @default.
• Q39442213 P577 Q39442213-36F0FC1B-8705-4DA2-9EE9-B25857A78B0E @default.
• Q39442213 P698 Q39442213-E79D20CA-7F05-4EFB-A209-844DD1F65E66 @default.
• Q39442213 P921 Q39442213-2450AB28-A458-408A-BD2B-6F83548158AF @default.
• Q39442213 P921 Q39442213-55A5F340-6951-4F56-BE23-E9F1B7C2F186 @default.
• Q39442213 P921 Q39442213-5FA66995-356D-47CE-92F9-9BC5806A39F1 @default.
• Q39442213 P921 Q39442213-7A9FB75B-1267-4F0B-9C71-282FB6424583 @default.
• Q39442213 P921 Q39442213-B709D5AC-D25C-4F5A-A9D5-B85ED74D193F @default.
• Q39442213 P356 J.IJCARD.2016.08.273 @default.
• Q39442213 P698 27573600 @default.
• Q39442213 P1433 Q2357863 @default.
• Q39442213 P1476 "Efficacy of alirocumab in high cardiovascular risk populations with or without heterozygous familial hypercholesterolemia: Pooled analysis of eight ODYSSEY Phase 3 clinical program trials" @default.
• Q39442213 P2093 "Bertrand Cariou" @default.
• Q39442213 P2093 "Daniel Gaudet" @default.
• Q39442213 P2093 "Kathryn Miller" @default.
• Q39442213 P2093 "Michel Farnier" @default.
• Q39442213 P2093 "Pascal Minini" @default.
• Q39442213 P2093 "Velichka Valcheva" @default.

• next